Photocatalytic process can carry out late-stage optimisation of drug candidates
A photocatalytic flow process activates simple gaseous alkanes for an atom economic late-stage alkylation of pharmaceutical heterocycles. The inherently scalable process employs cheap and abundant feedstocks to cleanly generate six distinct derivatives and could have a transformative impact on both drug discovery work and manufacturing.